Updated Jul 16, 2026
BURNETT JOSEPH has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.16M.
Joseph Burnett is the CEO and President of ClearPoint Neuro, Inc., a medical device company specializing in minimally invasive surgical procedures guided by MRI. He has been involved in the company's development and commercialization of innovative surgical platforms.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CLPT | ClearPoint Neuro, Inc. | A — Grant or award | 1.4K | $11.93 | $16K |
| 2026-07-01 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale | 20.0K | $19.38 | $388K |
| 2026-07-01 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 20.0K | $2.50 | $50K |
| 2026-06-22 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale | 1.8K | $17.94 | $33K |
| 2026-06-22 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale | 60.0K | $17.79 | $1.07M |
| 2026-06-22 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 60.0K | $2.50 | $150K |
| 2026-03-20 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 20.9K | $3.24 | $68K |
| 2026-03-16 | CLPT | ClearPoint Neuro, Inc. | F — Tax withholding / forfeiture | 43.2K | $11.53 | $498K |
| 2026-03-16 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 84.8K | — | |
| 2026-03-10 | CLPT | ClearPoint Neuro, Inc. | F — Tax withholding / forfeiture | 22.7K | $10.00 | $227K |
| 2026-03-10 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 47.4K | — | |
| 2026-03-05 | CLPT | ClearPoint Neuro, Inc. | F — Tax withholding / forfeiture | 9.5K | $8.84 | $84K |
| 2026-03-05 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise | 26.6K | — | |
| 2026-02-26 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale [10b5-1] | 20.0K | $15.17 | $303K |
| 2026-01-27 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale [10b5-1] | 2.9K | $15.57 | $46K |
| 2026-01-13 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale [10b5-1] | 20.0K | $16.12 | $322K |
| 2026-01-13 | CLPT | ClearPoint Neuro, Inc. | M — Option exercise [10b5-1] | 20.0K | $2.50 | $50K |
| 2026-01-05 | CLPT | ClearPoint Neuro, Inc. | A — Grant or award | 254 | $9.57 | $2K |
| 2025-10-10 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale | 300 | $29.21 | $9K |
| 2025-10-10 | CLPT | ClearPoint Neuro, Inc. | S — Open-market sale | 2.0K | $28.64 | $57K |
Joseph Burnett is the CEO and President of ClearPoint Neuro, Inc., a medical device company specializing in minimally invasive surgical procedures guided by MRI. He has been involved in the company's development and commercialization of innovative surgical platforms.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($3.16M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BURNETT JOSEPH profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.